Abstract
Background
Overall ocular magnification (OOM) and meridional ocular magnification (MOM) with consequent image distortions have been widely ignored in modern cataract surgery. The purpose of this study was to investigate OOM and MOM in a general situation with an astigmatic refracting surface.
Methods
From a large dataset containing biometric measurements (IOLMaster 700) of both eyes of 9734 patients prior to cataract surgery, the equivalent (PIOLeq) and cylindric power (PIOLcyl) were derived for the HofferQ, Haigis, and Castrop formulae for emmetropia. Based on the pseudophakic eye model, OOM and MOM were extracted using 4 × 4 matrix algebra for the corrected eye (with PIOLeq/PIOLcyl (scenario 1) or with PIOLeq and spectacle correction of the residual refractive cylinder (scenario 2) or with PIOLeq remaining the residual uncorrected refractive cylinder (blurry image) (scenario 3)). In each case, the relative image distortion of MOM/OOM was calculated in %.
Results
On average, PIOLeq/PIOLcyl was 20.73 ± 4.50 dpt/1.39 ± 1.09 dpt for HofferQ, 20.75 ± 4.23 dpt/1.29 ± 1.01 dpt for Haigis, and 20.63 ± 4.31 dpt/1.26 ± 0.98 dpt for Castrop formulae. Cylindric refraction for scenario 2 was 0.91 ± 0.70 dpt, 0.89 ± 0.69 dpt, and 0.89 ± 0.69 dpt, respectively. OOM/MOM (× 1000) was 16.56 ± 1.20/0.08 ± 0.07, 16.56 ± 1.20/0.18 ± 0.14, and 16.56 ± 1.20/0.08 ± 0.07 mm/mrad with HofferQ; 16.64 ± 1.16/0.07 ± 0.06, 16.64 ± 1.16/0.18 ± 0.14, and 16.64 ± 1.16/0.07 ± 0.06 mm/mrad with Haigis; and 16.72 ± 1.18/0.07 ± 0.05, 16.72 ± 1.18/0.18 ± 0.14, and 16.72 ± 1.18/0.07 ± 0.05 mm/mrad with Castrop formulae. Mean/95% quantile relative image distortion was 0.49/1.23%, 0.41/1.05%, and 0.40/0.98% for scenarios 1 and 3 and 1.09/2.71%, 1.07/2.66%, and 1.06/2.64% for scenario 2 with HofferQ, Haigis, and Castrop formulae.
Conclusion
Matrix representation of the pseudophakic eye allows for a simple and straightforward prediction of OOM and MOM of the pseudophakic eye after cataract surgery. OOM and MOM could be used for estimating monocular image distortions, or differences in overall or meridional magnifications between eyes.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
In modern cataract surgery, the retinal image size disparity is widely ignored [1,2,3]. The main reason for image size disparities is a mismatch between the biometric data of both eyes which include axial length, corneal curvature or power, or the axial position of the intraocular lens (IOL) implant. In general, intra-patient image size disparities are referred to as aniseikonia, but we have to strictly differentiate between a mismatch of overall retinal image sizes and a mismatch of retinal image size in different meridians which could be observed monocularly or binocularly [1, 4].
Ocular magnification (OM) refers to the ratio of retinal image size to the corresponding object size for objects at finite distances, and to the ratio of retinal image size to the incident ray angle (in radians) for objects at far distances [1]. With rotationally symmetric surfaces in the eye, we simply deal with overall ocular magnification (OOM) without variation of meridional ocular magnification (MOM), whereas for eyes with at least one toric surface, OM varies between meridians and the disparity between MEM in the magnification meridian and the magnification axis (DOM) causes image distortion. In simple cases where we deal with spherocylindric surfaces, a circle in the object space is translated to an ellipse in the image space, and the meridian of magnification refers to the semimajor axis having the largest MOM and the magnification axis refers to the semiminor axis of the ellipse where MOM is the smallest (Fig. 1).
Modern optical biometers and advanced IOL power prediction strategies can significantly reduce the prediction error of postoperative refraction and today in a highly selected cataract population 70 to 90% of eyes end up with a refractive prediction error within limits of ± 0.5 dioptre [5]. However, other mostly overlooked reasons for patient dissatisfaction are postoperative disparity of retinal image sizes between the two eyes of an individual or a meridional variation of retinal image size causing an image distortion [1, 2]. This can lead to headache, fusion problems, or in severe cases to a loss of stereopsis. From the literature, we know that aniseikonia is mostly below 0.5% in untreated eyes. An image size disparity of up to 2% is well tolerated by most patients, but retinal image size differences of 3% or more are sufficient to cause rapid fatigue [2, 6]. The tolerance of meridional retinal image sizes in terms of (monocular) image distortion or comparing both eyes of an individual has not yet been systematically investigated. Clinical measurement of retinal image size disparity is challenging and mostly unreliable and not part of routine clinical measurements [7]. Cohort studies or case reports which deal with aniseikonia are therefore rare. There are existing computer-based test strategies for aniseikona [3, 8] or classical test strategies [9, 10].
During ocular biometry prior to cataract surgery, all relevant data required for predicting the ocular magnification of both eyes are available [5]. Based on a schematic pseudophakic model eye, explicitly or implicitly defined by most of the (so-called theoretical-optical) IOL power calculation formulae, a number of parameters are obligatory to all calculation strategies—including axial length (AL) data, corneal front surface curvature data (radius in the flat meridian R1 in mm at flat axis Ra in ° and radius in the steep meridian R2 in mm at steep axis perpendicular to Ra), and the prediction of the effective lens position (ELP in mm). In addition, some formulae require more input data to specify the pseudophakic model eye such as the phakic anterior chamber depth (ACD in mm), the central thickness of the crystalline lens (LT in mm), or corneal back surface curvature data and central corneal thickness. The refractive indices of the aqueous (nA) and vitreous humour (nV) are typically derived from any classical schematic model eye, and the refractive indices of the cornea (nC) or the IOL (nIOL) are not required if the cornea and IOL are simplified using a thin lens model. In addition, the target refraction (TR in dpt) refers to the intended postoperative refraction at the spectacle plane.
Using the pseudophakic model eye underlying the IOL power calculation formula provides a simple and straight-forward option for estimating OOM [11, 12] and MOM [4, 13]. Using linear Gaussian optics (restricted to the paraxial space), OM can be derived in the pseudophakic eye for the spectacle-corrected eye (with any TR as correction), for the uncorrected eye (having a blurry image for any TR), or for the eye fully corrected by the IOL. For the simple case of rotationally symmetric refractive surfaces, a 2 × 2 matrix notation can be used for calculation [11], but for the more general case in which at least one surface in the eye is spherocylindric, a 4 × 4 matrix notation must be used [13].
The purpose of the present study was.
-
to develop and present a concept for predicting the overall and meridional ocular magnification of an eye in the post-cataract situation based on ocular biometry and linear Gaussian optics using 4 × 4 matrix algebra;
-
to predict the overall and meridional ocular magnification for both eyes of a patient:
-
for the situation of a toric intraocular lens fully correcting the eye for the intended target refraction,
-
and derive residual refraction for the situation of the respective non-toric intraocular lens (equivalent lens),
-
for the situation of an equivalent lens with a spectacle correction of the residual cylinder;
-
and to compare overall and meridional ocular magnification between both eyes of an individual based on a vector decomposition
using a large dataset from a cataract population measured with the IOLMaster 700 optical biometer.
Methods
Dataset for our analysis
For this retrospective study, we used a dataset containing a total of 32,198 biometrical measurements made with the IOLMaster 700 (Carl-Zeiss-Meditec, Jena, Germany) from two clinical centres (Augenklinik Castrop, Castrop-Rauxel, Germany, and Department of Ophthalmology, Johannes Kepler University Linz, Austria). All measurements were performed in a cataractous population, excluding pseudophakic eyes. Duplicate measurements of eyes, eyes in pharmacologically stimulated mydriasis (pupil width more than 5.2 mm), and incomplete records in the dataset were discarded. Measurement data indexed as being after refractive surgery, or having ectatic corneal diseases or other corneal pathologies were omitted from the dataset. The data were exported to a.csv data table using the data backup module of the IOLMaster 700 software. Data tables were reduced to the relevant parameters required for our data analysis, consisting of laterality (left or right eye), patient’s date of birth and examination date of the eyes, curvature of the corneal front surface (flat meridian: R1 at Ra; steep meridian: R2 perpendicular to Ra), ACD measured from the corneal front apex to the crystalline lens front apex in mm, and LT. The data were transferred to Matlab (Matlab version 2019b, MathWorks, Natick, USA) for further processing. The local ethics committee provided a waiver for this study (Ärztekammer des Saarlandes, 157/21).
Preprocessing of the data
Custom software for data processing and analysis was written in Matlab. From the entire dataset, we selected patients with bilateral measurements taken on the same examination day, with all other examinations being discarded. Each patient’s age (age in years) was derived from their date of birth and the examination date. Without loss of generality, target refraction was set to zero (emmetropisation), the refractive indices of aqueous and vitreous humour were set to nA = nV = 1.336 (for the Castrop formula, the refractive index of the cornea was set to nC = 1.376), and the back vertex distance for the spectacle correction was set to 12 mm. For comparison of both eyes of an individual, the dataset was split into right eyes (OD) and left eyes (OS).
Toric intraocular lens power calculation and prediction of ocular magnification
Three different vergence-based formulae were used for calculating the intraocular lens power: the HofferQ formula [14], the Haigis formula [15], and the Castrop formula [16]. The HofferQ formula and the Haigis formula are based on a pseudophakic schematic model eye with 3 refracting surfaces (TR at spectacle plane, cornea as thin lens, and IOL as thin lens). In contrast to the HofferQ and Haigis formulae, the Castrop formula uses a pseudophakic schematic model eye with 4 refractive surfaces (TR at spectacle plane, cornea as a thick lens with front and back surface, and IOL as a thin lens). According to the formula definitions, the corneal power in both corneal meridians was calculated from R1 and R2 using the respective keratometer index (1.3375 and 1.3315 for the HofferQ and Haigis formulae) or for the corneal front and back surface using the refractive index of the cornea and aqueous humour for the Castrop formula. The formula constants were extracted from the IOLCon WEB site (https://iolcon.org, accessed on 20.03.2022) for the Tecnis lens (Johnson & Johnson, Brunswick, USA).
Lens power calculation, derivation of residual refraction, and extraction of OM for the corrected or uncorrected pseudophakic eye were performed using matrix algebra for toric optical systems [4, 13]. In general, the 4 × 4 power matrix P and the 4 × 4 translation matrix T are defined as:
where U refers to the 2 × 2 unity matrix, Z to the 2 × 2 zero matrix, and the 2 × 2 matrices P2 and T2 defined by
Pf, Ps, and Pa describe the power in the flat and steep meridian and the axis of the flat meridian of a spherocylindric refractive surface, and d and n describe the geometric distance between subsequent surfaces and the refractive index of the optical medium [11]. The system matrix S, defined as the product of all power and translation matrices from object to image in reversed order, describes the properties of the entire optical system. With the 4 × 4 system matrix S, the slope (\(\alpha =\left[\begin{array}{c}{\alpha }_{x}\\ {\alpha }_{y}\end{array}\right]\) in X and Y) and height (\(h=\left[\begin{array}{c}{h}_{x}\\ {h}_{y}\end{array}\right]\) in X and Y) of the exiting ray are described by the respective slope and the height of the incident ray (α0 and h0) by:
For a model with 3 refracting surfaces (pseudophakic model for the HofferQ or the Haigis formula) and objects at infinity, the system matrix reads:
where PIOL, PC, PTR, TV, TELP, and TVD refer to the power matrices for the IOL, the cornea, the target refraction and to the translation matrices for the vitreous, the pseudophakic effective lens position, and the back vertex distance (which for this study was set to 12 mm without loss of generality).
For a model with 4 refracting surfaces (pseudophakic model for the Castrop formula) and objects at infinity, the system matrix reads:
where PIOL, PCP, PCA, PTR, TV, TELP-CCT, TCCT, and TVD refer to the power matrices for the IOL, the posterior and anterior corneal surfaces, the target refraction and to the translation matrices for the vitreous humour, the pseudophakic aqueous depth (effective lens position minus central corneal thickness (CCT)), the CCT, and the vertex distance. For simplification, CCT was set to 550 µm and instead of the measured corneal back surface curvature, the respective front surface curvature data scaled with a fixed ratio of 0.84 (0.84·R1 and 0.84·R2 for the flat and steep meridian) were used.
For calculation of the toric lens implant, we consider \(S=T_{\mathrm V}\cdot P_{\mathrm{IOL}}\cdot S_{\mathrm{SUB}}\) with the subsystem matrix SSUB defined by \(S_{\mathrm{SUB}}=T_{\mathrm{ELP}}\cdot P_{\mathrm C}\cdot T_{\mathrm{VD}}\cdot P_{\mathrm{TR}}\) for the HofferQ and the Haigis formulae or \({S_{\mathrm{SUB}}=T}_{\mathrm{ELP}-\mathrm{CCT}}\cdot P_{\mathrm{CP}}\cdot T_{\mathrm{CCT}}\cdot P_{\mathrm{CA}}\cdot T_{\mathrm{VD}}\cdot P_{\mathrm{TR}}\) for the Castrop formula. For the corrected optical model, the lower right 2 × 2 matrix of S (SD) must be zero:
and after a short formula conversion, the upper right 2 × 2 matrix of PIOL reads:
The 2 cardinal meridians (flat meridian PIOLf with axis PIOLa and steep meridian PIOLs) are extracted from P2IOL using an eigenvalue decomposition. The equivalent power PIOLeq and the cylindric power PIOLcyl of the toric IOL implant are given by PIOLeq = 0.5·(PIOLf + PIOLs) and PIOLcyl = PIOLs-PIOLf.
In the next step, the IOL with the equivalent power PIOLeq is inserted and the residual (cylindric) refraction at the spectacle plane derived. The system matrix S is reformulated to:
with the subsystem matrix SSUB defined by \(S_{\mathrm{SUB}}=T_{\mathrm V}\cdot P_{\mathrm{IOL}}\cdot T_{\mathrm{ELP}}\cdot P_{\mathrm C}\cdot T_{\mathrm{VD}}\) for the HofferQ and the Haigis formulae or \(S_{\mathrm{SUB}}=T_{\mathrm V}\cdot P_{\mathrm{IOL}}\cdot T_{\mathrm{ELP}-\mathrm{CCT}}\cdot P_{\mathrm{CP}}\cdot T_{\mathrm{CCT}}\cdot P_{\mathrm{CA}}\cdot T_{\mathrm{VD}}\) for the Castrop formula, and the power matrix PREF describing the residual refraction at the spectacle plane. As the entire system is fully corrected with the (cylindric) spectacles, the lower right 2 × 2 matrix of S (SD) must be zero (Z). After a short formula conversion, we obtain that the upper right 2 × 2 matrix of PTR (P2REF) reads:
Again, the 2 cardinal meridians (flat meridian PREFf with axis PREFa and steep meridian PREFs) are extracted from P2REF using an eigenvalue decomposition. As the rotationally symmetric equivalent lens was considered, the spherical equivalent refraction is zero, and the cylindric refraction PREFcyl reads PREFcyl = PREFs − PREFf.
The 2 × 2 matrix M characterising OM is directly extracted from the 4 × 4 system matrix. In fully corrected systems, the lower right 2 × 2 matrix SD equals Z, and the OM is calculated from the lower left 2 × 2 matrix SC (M = SC). This is true for the situation where a fully correcting toric IOL is implanted or for the case where a rotationally symmetric IOL (e.g. with the equivalent power PIOLeq) is implanted and the residual refraction corrected at the spectacle plane. In situations where an IOL with its equivalent power is implanted and the residual refraction (refractive cylinder) remains uncorrected, both 2 × 2 matrices SC and SD are unequal to Z. This means that not all rays from the object passing through the optical system hit the same point in the image plane and the image will be blurred [12]. To extract OM for this blurry image, we e.g. identify the chief ray which passes through the pupil centre (assumed to be located within ACD behind the corneal front vertex). Expressed in matrix notation, we define the matrix characterising the subsystem from the object to the pupil plane as (\(S_{\mathrm{PUP}}=T_{\mathrm{ELP}}\cdot P_{\mathrm C}\cdot T_{\mathrm{VD}}\cdot P_{\mathrm{TR}}\) for the HofferQ and the Haigis formulae or \(S_{\mathrm{PUP}}=T_{\mathrm{ELP}-\mathrm{CCT}}\cdot P_{\mathrm{CP}}\cdot T_{\mathrm{CCT}}\cdot P_{\mathrm{CA}}\cdot T_{\mathrm{VD}}\cdot P_{\mathrm{TR}}\) for the Castrop formula) and postulate that
After some formula conversion, we obtain that the 2 × 2 matrix M characterising OM for the uncorrected optical system reads:
The meridional ocular magnification MOM in 2 cardinal meridians (magnification MOM1 in the magnification axis MOMa and magnification MOM2 in the magnification meridian) are extracted from M using eigenvalue decomposition. The mean overall ocular magnification OOM and the disparity between OM in the magnification meridian and the magnification axis DOM are calculated by OOM = 0.5·(MOM1 + MOM2) and DOM = (MOM2 − MOM1).
For calculating the difference between OM of both eyes, vector decomposition was performed to extract the components in the 0°/90° and in 45°/135° orientations. For symmetry reasons, the axis of all left eyes was mirrored at the vertical axis, meaning that the vector components in 45°/135° were flipped in sign [12]. Then the component for the right eyes was subtracted from the respective component for the left eye (ΔMEM0°/90° = MEM0°/90° (for left eyes) − MEM0°/90° (for right eyes); and ΔMEM45°/135° = − MEM0°/90° (for left eyes) − MEM0°/90° (for right eyes).
Statistics and linear prediction model for ocular magnification
The biometric data of the entire dataset, for right eyes and for left eyes, as well as the respective differences between left and right eyes, are shown descriptively with mean (MEAN), standard deviation (STD), median (MEDIAN), as well as the lower and upper boundaries of the 90% (CL90L and CL90U) confidence intervals. In an explorative analysis, the OM (OOM and DOM) is shown for scenario 1 with a fully correcting toric intraocular lens calculated for emmetropia, for scenario 2 with a non-toric equivalent lens and (sphero-)cylindric spectacle correction, as well as for scenario 3 with a non-toric equivalent lens without correction of the cylinder (blurred image). Data for the toric IOL (scenario 1) are provided in spherical equivalent power PIOLeq and cylinder power PIOLcyl, data for the residual refraction at the spectacle plane with implantation of the spherical equivalent lens (scenario 2) are given in cylinder power PREFcyl, and the ocular magnification for scenarios 1–3 is shown with overall ocular magnification OOM and with DOM values as the disparity in ocular magnification between the magnification meridian and magnification axis.
Results
After quality approval of the dataset and filtering out incomplete data and patients with only one eye measured, a total of N = 9734 patients (measurements of 9734 right and 9734 left eyes, 5492 female and 4242 male patients, 5467 patients from Augenklinik Castrop and 4267 patients from Department of Ophthalmology, Johannes Kepler University Linz) were enrolled in our study. The mean age of the study population was 69 ± 15 years (median 73 years, 90% confidence interval from 43 to 85 years). Mean axial length was 23.68 ± 1.40 mm (confidence interval 21.84 to 26.14 mm). Table 1 shows the explorative data for the biometric parameters AL, CCT, ACD, LT, R1, and R2 for the entire dataset (N = 19,468 eyes), the dataset of OD and the dataset of OS, together with the difference between OS and OD (values shown are scaled by × 100).
In Table 2, the explorative data for the refractive power of the toric intraocular lens derived with the HofferQ, the Haigis, and the Castrop formulae are displayed in terms of equivalent power PIOLeq and cylindric power PIOLcyl, together with the prediction of the cylindric residual refraction at the spectacle plane with the equivalent lens (PIOLeq) implanted instead of the toric lens. Data are shown for the entire dataset (N = 19,468 eyes) as well as separately for the dataset of OD and the dataset of OS (each N = 9734). Figure 2a provides the scatterhist for the power of the toric lens. On the X / Y axis of the scatterplot, the cylindric power PIOLcyl / equivalent power (PIOLeq) of the toric lens derived with the HofferQ, the Haigis, and the Castrop formulae respectively is provided. The graph on the left shows the kernel distribution for the equivalent power of the toric lens PIOLeq, and the graph below the scatterplot shows the kernel distribution for the cylindric power of the toric lens PIOLcyl. Figure 2b displays the normalised histogram for the predicted refractive cylinder where a non-toric intraocular lens with the equivalent power PIOLeq is implanted instead of a toric lens. As the biometer used for this study does not provide curvature data separately for the flat and steep corneal meridian for very small values of corneal astigmatism, the distributions of PIOLcyl in Fig. 2a and PREFcyl in Fig. 2b do not show values close to zero.
Table 3 summarises the explorative data for OOM and DOM in scenario 1 (implantation of a fully correcting toric IOL), scenario 2 (implantation of a non-toric equivalent lens and spectacle correction of the residual cylindric refraction at spectacle plane), and scenario 3 (implantation of a non-toric equivalent lens without correction of the residual refraction) for the entire dataset and the subsets OD and OS. The magnification meridian / magnification axis in scenarios 1 and 3 is the steep / flat meridian of the cornea, whereas in scenario 2 the situation is reversed and the magnification meridian / magnification axis refers to the flat meridian / steep meridian of the cornea.
Figure 3 shows the overall ocular magnification OOM and the disparity of ocular magnification DOM based on calculations according to the pseudophakic model eyes used with the HofferQ, the Haigis, and the Castrop formulae. In situation 1 (upper graph, Fig. 3a), the corneal astigmatism is fully corrected by a toric lens implant, and the magnification meridian / magnification axis coincides with the steep corneal meridian. In situation 2 (middle graph, Fig. 3b), a non-toric equivalent lens is considered and the corneal astigmatism is fully corrected by a (cylindric) spectacle correction. In this situation, the magnification meridian / magnification axis coincides with the meridian where the spectacle correction shows its highest / lowest power (flat / steep corneal meridian). In situation 3 (lower graph, Fig. 3c), the same lens as in situation 2 is considered but the refractive cylinder remains uncorrected. In this situation, the magnification meridian / magnification axis again coincides with the steep / flat corneal meridian. In general, correction of the refractive cylinder with spectacles (situation 2) causes a systematically larger amount of DOM compared to a correction with a toric lens (situation 1) or corneal astigmatism which remains uncorrected (situation 3).
Figure 4 displays the intra-individual differences in ocular magnification between the left eye and the right eye of the 3 situations under test: the upper graph (situation 1, Fig. 4a) refers to a corneal astigmatism fully corrected by a toric lens implant for emmetropia, the middle graph (situation 2, Fig. 4b) to a non-toric lens implant calculated for emmetropic spherical equivalent refraction with correction of the residual cylinder at the spectacle plane, and the lower graph (situation 3, Fig. 4c) considers the same lens as in situation 2 but without correction of the residual cylinder (blurry image). The histograms show the difference in overall magnification OOM between both eyes, and the scatterplots display the differences in the vector components of MOM considered at 0°/90° meridians (X-axis) and 45°/135° meridians (Y-axis). Situation 2 shows a systematically larger scatter (SD of MOM X-axis / Y-axis with HofferQ: 0.1400/0.1228 e-3 mm/mrad, with Haigis: 0.1382/0.1211 e-3 mm/mrad, and with Castrop 0.1376/0.1206 e-3 mm/mrad) compared to situations 1 (SD of MOM X-axis / Y-axis with HofferQ: 0.0641/0.0565 e-3 mm/mrad, with Haigis: 0.0549/0.0483 e-3 mm/mrad, and with Castrop 0.0517/0.0455 e-3 mm/mrad) and 3 (SD of MOM X-axis / Y-axis with HofferQ: 0.0640/0.0565 e-3 mm/mrad, with Haigis: 0.0549/0.0484 e-3 mm/mrad, and with Castrop 0.0516/0.0457 e-3 mm/mrad). The marks in the scatterplots refer to the median centroids and indicate that no systematic differences between the two eyes are observed. For situation 1, the marks are located at coordinates X/Y = 14/38·e-7 mm/mrad (blue x) for HofferQ, X/Y = 11/32·e-7 mm/mrad (red circle) for Haigis, and X/Y = 12/31·e-7 mm/mrad (green dot) for Castrop. The respective marks for situation 2 are at coordinates X/Y = − 30/ − 85·e-7 mm/mrad for HofferQ, X/Y = − 29/ − 84·e-7 mm/mrad for Haigis, and X/Y = − 29/ − 84·e-7 mm/mrad for Castrop, and for situation 3 at coordinates X/Y = 13/38·e-7 mm/mrad for HofferQ, X/Y = 11/32·e-7 mm/mrad for Haigis, and X/Y = 12/31·e-7 mm/mrad for Castrop, respectively. Without considering the symmetry and flipping the sign of the vector components at 45°/135° for left eyes, the median centroids are located at Y = 67/57/54·e-7 mm/mrad with the HofferQ/Haigis/Castrop formula for situation 1, − 152/ − 149/ − 149·e-7 mm/mrad for situation 2, and Y = 67/57/54·e-7 mm/mrad for situation 3.
Discussion
It is well accepted in ophthalmology that anisometropia in terms of a disparity of distances between both eyes of an individual or differences in curvatures or power of refractive surfaces could cause aniseikonia [1, 17, 18]. However, even where all data for predicting ocular magnification of the pseudophakic eye are available with biometry prior to cataract surgery, IOL power calculation software typically does not provide such predictions. Furthermore, ophthalmologists might be unaware that spherocylindric elements in the eye may cause image distortions in a way that a circle or square in the object plane would be imaged to an ellipse or rectangle/rhombus in the retinal image plane. In a paraxial simplification, in a fully corrected optical system, all rays starting from an object point and passing through the system end up at the corresponding image point irrespective of the optical pathway [11, 12]. This implies that one single element in the system matrix in the second row characterises ocular magnification whereas the second element equals zero. When considering objects at infinity, the object size is undefined and ocular magnification refers to the retinal image size subdivided by the incident ray angle in radians (lower left element in the system matrix). When dealing with objects at finite distances, magnification refers to the ratio of image size to object size and the lower right element in the system matrix yields ocular magnification. For optical systems with astigmatic surfaces, we have to generalise this calculation strategy to 4 × 4 matrices instead of 2 × 2 matrices, and the 4 × 4 matrix is subdivided into four 2 × 2 submatrices [4, 13]. These 2 × 2 submatrices have the same meaning in an astigmatic system as the matrix elements in a non-toric system, but include information on the behavior of both cardinal meridians and the respective orientations, which can be extracted from the 2 × 2 matrix using eigenvalue decomposition.
Image distortions in optical systems with astigmatic surfaces are per se monocular effects. However, if both eyes of an individual include astigmatic surfaces, the distortions may or may not match between eyes (in absolute value and/or in direction). This means that in the best case the distortions are aligned, and in the worst case the magnification meridians of both eyes are perpendicular to each other, potentially making fusion of both retinal images difficult. Currently, there are no reliable clinical data on the tolerance of meridional magnification disparities, and there is no device on the market able to measure image distortion at the retina [7, 9]. However, in cataract surgery, preoperative biometry makes possible the option of estimating the amount of overall magnification disparity as well as the meridional disparity for the postoperative situation in the (spectacle) corrected or the uncorrected pseudophakic eye. Our results indicate that different lens power calculation concepts based on different pseudophakic model eyes yield slightly different results in the toric IOL power, the residual refraction, and in the OOM and MOM. However, these differences are rather small, meaning that that prediction of OM could be performed directly with the calculation concept that we use in our routine setting for lens power calculation.
If we consider the situation of a single eye, the results of IOL power, residual refraction, or OOM and MOM can be presented without vector decomposition into the 0°/90° and 45°/135° meridians. If we reference to the principal corneal meridians and fully correct corneal astigmatism with a toric lens or spherocylindric spectacles, the magnification conditions are quite different. With a toric lens the DOM is much lower compared to a correction of corneal astigmatism with spectacles, and the magnification meridian is located at the steep corneal meridian compared to the flat corneal meridian with spectacle correction. If corneal astigmatism remains uncorrected, the magnification meridian of the blurry image also coincides with the steep corneal meridian. However, in the general case where astigmatic surfaces are not axially aligned (crossed cylinders) or where more than 2 astigmatic surfaces are considered, general statements about the amount or orientation of the magnification meridians are not possible. Nevertheless, the calculation scheme presented in this paper could be applied in general to corrected or uncorrected optical systems with arbitrary numbers of astigmatic surfaces with cylinder axes in random orientations.
Surprisingly, a large number of eyes in a cataractous population would benefit from a toric lens implantation. Referring to the data of toric power of the IOL shown in Table 2 or to scatterhist in Fig. 2a, there is a wide range of toric IOL power with a range mostly between 0 and 5 dpt and a median of around 1.0 to 1.1 dpt. We have to be aware that for small values of corneal astigmatism the IOLMaster 700 seems to provide identical corneal radii R1 and R2 for both corneal meridians instead of a steep and flat meridian both with orientations, and the respective distribution of the toric IOL power lacks of data for values close to zero. If corneal astigmatism remains uncorrected due to implantation of a non-toric equivalent IOL, we could expect a residual cylinder at the spectacle plane ranging mostly between 0 and 4 dpt and with a median value of around 0.72 to 0.74 dpt (see also Table 2 and Fig. 2b). If we extract the relative distortion (DOM/OOM in %) from the data shown in Table 3, we obtain for the entire dataset 0.4884 ± 0.3888% / 1.0907 ± 0.8442% / 0.4884 ± 0.3887% for scenarios 1 / 2 / 3 with the HofferQ formula, 0.4187 ± 0.3309% / 1.0714 ± 0.8292% / 0.4187 ± 0.3309% for the Haigis formula, and 0.3968 ± 0.3085% / 1.0622 ± 0.8222% / 0.3968 ± 0.3085% for the Castrop formula, respectively. The respective upper boundary of the 90% confidence interval is 1.2316% / 2.7087% / 1.2316% for the HofferQ, 1.0538% / 2.6606% / 1.0538% for the Haigis, and 0.9824% / 2.6381% / 0.9824% for the Castrop formulae. This means that 5% of eyes after cataract surgery end up with an image distortion of 2.6 to 2.7% or more when a non-toric IOL is implanted and the residual cylinder corrected with spectacles, in contrast to around 1% distortion if a fully correcting toric IOL is implanted.
Comparing OOM of the left and right eye as shown in the histograms of Fig. 4, we find that the differences are mostly within limits of ± 0.0005 mm/mrad, which corresponds to a relative magnification difference of around ± 3%. As we aim for emmetropia in all 3 scenarios, there is no noticeable difference between OOM of both eyes comparing scenarios 1, 2, and 3. However, considering the difference in MOM between left and right eyes, we see a small scatter around zero for scenarios 1 and 3, but a much larger scatter for scenario 2 where a non-toric IOL is used and the residual cylindrical refraction is corrected at the spectacle plane. The median centroids as marked in the scatterplots of Fig. 4 are all located close to zero, and the distributions of the data points quite similar in X and Y direction. This indicates that our assumption of symmetry of left and right eyes with respect to the vertical axis is justified. If we do not consider such symmetry and do not flip the sign of the MOM vector components in 45°/135° for left eyes, the location of the median centroid shows a much larger shift in the Y direction (data in the “Results” section).
There are some limitations to our study: first of all, we used linear Gaussian optics for lens power calculation and for calculation of ocular magnification. This means that the calculations are restricted to paraxial rays and small ray angles. Unlike in linear optics, using full aperture raytracing ocular magnification cannot be defined in general as a function of biometric measures, since it depends on the ray height and the incident ray angle. In addition, we have assumed that the prediction of the axial lens position, as implicitly provided by several theoretical-optical lens power calculation formulae, sufficiently reflects the true axial lens position after cataract surgery. As we know, the effective lens position is used in some formulae to compensate for measurement or interpretation errors of biometric measures (e.g. converting corneal curvature to corneal power using a keratometer index) and this may slightly bias the result of our magnification prediction. Most of the lens power calculation formulae work on the basis of simplified thin lens models for the cornea, the intraocular lens, or both. The calculation scheme presented in this paper could, in general, deal with thick lens models for the cornea (as shown with the Castrop formula) or for the intraocular lens, provided that the geometry data of the corneal back surface (including corneal thickness) or the design data of the intraocular lens (front and back surface curvature, central thickness, and refractive index) are available. And last but not least, we restricted the study to prediction of retinal image sizes or disparities in overall or meridional magnification in terms of a transfer from the object size to the retinal image size. However, several other parameters of image processing in the retina or the visual cortex may play a role for the subjective tolerance of image size disparities, and these have not been considered in our calculation strategy.
In conclusion, from a routine biometry measurement prior to cataract surgery, we have all relevant measures required to predict overall and meridional ocular magnification for the pseudophakic eye after cataract surgery. With a pseudophakic optical model which is implicitly or explicitly defined by most of the lens power calculation concepts, the overall and meridional magnification can be extracted using simple matrix algebra. From the overall magnification, we could derive postoperative aniseikonia as the difference in retinal image sizes of both eyes. From meridional magnification, we could extract image distortion monocularly and/or the differences between left and right eye using vector decomposition. A prediction of ocular magnification during lens power calculation during biometry prior to cataract surgery may help to avoid eikonic problems as with a selection of equivalent and toric lens power and planning the target refraction aniseikonia and image distortions could be controlled within limits.
References
Achiron LR, Witkin N, Primo S, Broocker G (1997) Contemporary management of aniseikonia. Surv Ophthalmol 41(4):321–30. https://doi.org/10.1016/s0039-6257(96)00005-7
Langenbucher A, Szentmáry N (2008) Anisometropie und Aniseikonie—ungelöste Probleme der Kataraktchirurgie [Anisometropia and aniseikonia–unsolved problems of cataract surgery]. Klin Monbl Augenheilkd 225(9):763–769. https://doi.org/10.1055/s-2008-1027601
Rutstein RP, Corliss DA, Fullard RJ (2006) Comparison of aniseikonia as measured by the aniseikonia inspector and the space eikonometer. Optom Vis Sci 83(11):836–842. https://doi.org/10.1097/01.opx.0000238722.34167.cc
Langenbucher A, Seitz B, Szentmáry N (2007) Modeling of lateral magnification changes due to changes in corneal shape or refraction. Vision Res 47(18):2411–2417. https://doi.org/10.1016/j.visres.2007.05.015
Fișuș AD, Hirnschall ND, Ruiss M, Pilwachs C, Georgiev S, Findl O (2021) Repeatability of 2 swept-source OCT biometers and 1 optical low-coherence reflectometry biometer. J Cataract Refract Surg 47(10):1302–1307. https://doi.org/10.1097/j.jcrs.0000000000000633
Krarup TG, Nisted I, Christensen U, Kiilgaard JF, la Cour M (2020) The tolerance of anisometropia. Acta Ophthalmol 98(4):418–426. https://doi.org/10.1111/aos.14310
Bourdy C, James Y (2016) Eiconomètre électronique : tests de mesure présentés sur écran stéréoscopique [Electronic eikonometer: Measurement tests displayed on stereoscopic screen]. J Fr Ophtalmol 39(5):449–458. https://doi.org/10.1016/j.jfo.2015.12.007
Fullard RJ, Rutstein RP, Corliss DA (2007) The evaluation of two new computer-based tests for measurement of Aniseikonia. Optom Vis Sci 84(12):1093–1100. https://doi.org/10.1097/OPX.0b013e31815b9e4c
Krarup T, Nisted I, Kjaerbo H, Christensen U, Kiilgaard JF, la Cour M (2021) Measuring aniseikonia tolerance range for stereoacuity - a tool for the refractive surgeon. Acta Ophthalmol 99(1):e43–e53. https://doi.org/10.1111/aos.14507
Willeford KT, Butera M, LeBlanc J, Sample A (2020) Field-wide quantification of aniseikonia using dichoptic localization. Optom Vis Sci 97(8):616–627. https://doi.org/10.1097/OPX.0000000000001548
Haigis W (2009) Matrix-optical representation of currently used intraocular lens power formulas. J Refract Surg 25(2):229–234. https://doi.org/10.3928/1081597X-20090201-09
Langenbucher A, Szentmáry N, Leydolt C, Cayless A, Schwarzenbacher L, Zsolt Nagy Z, Menapace R (2021) Calculation of ocular magnification in phakic and pseudophakic eyes based on anterior segment OCT data. Ophthalmic Physiol Opt 41(4):831–841. https://doi.org/10.1111/opo.12822
Langenbucher A, Reese S, Huber S, Seitz B (2005) Compensation of aniseikonia with toric intraocular lenses and spherocylindrical spectacles. Ophthalmic Physiol Opt 25(1):35–44. https://doi.org/10.1111/j.1475-1313.2004.00243.x
Hoffer KJ (1993) The Hoffer Q formula: a comparison of theoretic and regression formulas. J Cataract Refract Surg 19(6):700–712. https://doi.org/10.1016/s0886-3350(13)80338-0
Haigis W, Lege B, Miller N, Schneider B (2000) Comparison of immersion ultrasound biometry and partial coherence interferometry for intraocular lens calculation according to Haigis. Graefes Arch Clin Exp Ophthalmol 238(9):765–773. https://doi.org/10.1007/s004170000188
Langenbucher A, Szentmáry N, Cayless A, Weisensee J, Fabian E, Wendelstein J, Hoffmann P (2021) Considerations on the Castrop formula for calculation of intraocular lens power. PLoS One 16(6):e0252102. https://doi.org/10.1371/journal.pone.0252102
Hashemi H, Khabazkhoob M, Emamian MH, Shariati M, Abdolahi-nia T, Fotouhi A (2013) All biometric components are important in anisometropia, not just axial length. Br J Ophthalmol 97(12):1586–1591. https://doi.org/10.1136/bjophthalmol-2013-303939
Rajan MS, Bunce C, Tuft S (2008) Interocular axial length difference and age-related cataract. J Cataract Refract Surg 34(1):76–79. https://doi.org/10.1016/j.jcrs.2007.08.023
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
No funding was received for this research. Dr. Wendelstein reports speaker fees from Carl Zeiss Meditec AG, Alcon, and Johnson & Johnson Vision outside of the submitted work. Dr. Langenbucher reports speaker fees from Hoya Surgical and Johnson & Johnson Vision outside the submitted work. Dr. Hoffmann reports speaker fees from Hoya Surgical and Johnson & Johnson outside the submitted work.
The local ethics committee provided a waiver for this study (Ärztekammer des Saarlandes, 157/21). All data processed in this study were already anonymized at the source before they were transferred to us for processing. Any back-tracing of the identity is not possible; therefore, an informed consent of the patient was not necessary.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Langenbucher, A., Hoffmann, P., Cayless, A. et al. Meridional ocular magnification after cataract surgery with toric and non-toric intraocular lenses. Graefes Arch Clin Exp Ophthalmol 260, 3869–3882 (2022). https://doi.org/10.1007/s00417-022-05740-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-022-05740-4